本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Protagonist Therapeutics Inc

148.18
+3.022.08%
盤後148.180.00000.00%19:30 EDT
成交量:47.80萬
成交額:7,061.77萬
市值:95.88億
市盈率:143.86
高:150.48
開:147.18
低:145.82
收:145.16
52周最高:160.81
52周最低:57.90
股本:6,470.83萬
流通股本:6,316.60萬
量比:0.91
換手率:0.76%
股息:- -
股息率:- -
每股收益(TTM):1.03
每股收益(LYR):-2.0500
淨資產收益率:10.98%
總資產收益率:4.55%
市淨率:11.39
市盈率(LYR):-72.28

資料載入中...

2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2025/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/10/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/09/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/06

重要事件披露

Form 8-K - Current report
2025/07/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/26

重要事件披露

Form 8-K - Current report
2025/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities